Mila de Moura Behar Pontremoli Salcedo

Tulane University of Louisiana

8 Sept 2026reporter.nih.gov

National Cancer Institute

U01A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in MozambiqueU01CA2946742024–20298 Sept 2026reporter.nih.gov

National Cancer Institute

U01A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in MozambiqueU01CA2946742024–202926 Aug 2026reporter.nih.gov